Table 5 The most targeted diseases stratified by origin of sponsor
From: Map of biomedical research in Cameroon; a documentary review of approved protocols from 1997 to 2012
Diseases | Total (%) | Local sponsors (%) | International Sponsor (%) | p-value |
|---|---|---|---|---|
Diabetes | 101 (7.6) | 90 (8.1) | 11 (5.1) | 0.13 |
HIV/AIDS | 342 (25.8) | 306 (27.6) | 36 (16.7) | <0.001 |
Malaria | 136 (10.3) | 99 (8.9) | 37 (17.2) | <0.001 |
Tuberculosis | 44 (3.3) | 39 (3.5) | 5 (2.3) | 0.37 |
Reproductive Health | 33 (2.5) | 29 (2.6) | 4 (1.9) | 0.55 |
Cancers | 77 (5.8) | 53 (4.8) | 24 (11.2) | <0.001 |
Neurological/Mental Health | 61 (4.6) | 49 (4.4) | 12 (5.6) | 0.44 |
Cardiovascular Diseases | 64 (4.8) | 57 (5.1) | 7(3.3) | 0.26 |
Metabolic Diseases | 37 (2.8) | 33 (3.0) | 4 (1.9) | 0.37 |
Digestive System | 54 (4.1) | 51 (4.6) | 3 (1.4) | 0.03 |
Tropical/Infectious Diseases | 126 (9.5) | 107 (9.7) | 19 (8.8) | 0.68 |
Eye Diseases | 19 (1.4) | 15 (1.3) | 4 (1.9) | 0.49 |
Respiratory system diseases | 38 (2.9) | 29 (2.6) | 9 (4.2) | 0.20 |
STI/STD | 17(1.3) | 14(1.3) | 3 (1.4) | 0.91 |
Hepatitis | 44 3.3) | 35(3.20) | 9 (4.2) | 0.46 |
Others | 130 (9.8) | 102 (9.2) | 28 (13.0) | 0.09 |
Total | 1323 | 1108 | 215 |